PBAC's latest decision on Milk powder - lactose intolerance formula: Recommended with restriction (2017). Considered for Treatment of acute lactose intolerance in infants up to 12 months of age.
PBAC outcome
Recommended with restriction
Authority Required
ICER (AUD/QALY)
Cost-min
cost-minimisation analysis
Submissions
1
first 2017
Submissions
1
2017 → 2017
Eligible population
Infants up to 12 months of age with acute lactose intolerance.
Therapy area
Other
Line of therapy
Not applicable
Evidence base
Cost-minimisation
Primary endpoint
Cost-minimisation
Comparator
S-26 LF (milk powder lactose-free formula)
Economic model
Cost-minimisation
ICER note
Cost-minimisation analysis; no ICER calculated as this is a minor submission with equivalent pricing to the comparator product.